1[1]Petersenu DA.Endremann R.Invitro activity of BAY12-8039,a new 8-methoxyquinolone[J].Chemotherapy,1996,42:410-25. 被引量：1
2[2]Riickdeschel G,Dalhoff A.The in vitro activity of moxifloxacin against legionella species and the effects of medium on susceptibility test results[J].J Antimicrob Chemother,1999,43(suppl B):25-29. 被引量：1
3[3]Stass H,Dalhoff A,Kubitza D,et al.Pharmacokinetics,safety,and tolerability of ascending single doses of moxifloxacin,a new 8-methoxy guinolone,administered to healthy subjects[J].Antimicrob Agents Chemother,1998,42:2060. 被引量：1
1DalhoffA, Petersenu, Endremann R. Invitro activity of BAY12 -8039, a new 8 -methoxyquinolone. Chemotherapy, 1996,42:410-25. 被引量：1
2Woodcock JM, Anerews JM, Boswell FJ, et al. In vitro activity of BAY 12-8039, a new fluoroguinolone. Antimicrob Agents Chemother, 1997,41 : 101-1. 被引量：1
3MacGowan AP, Bowker KE, Holt HA, et al. BAY 12-8039, a new 8 - methoxyquindone:comparative in vitro activity with nine other antimicrobials against anaerobic. J Antimicrob Chemother, 1997,40:503-9. 被引量：1
4Riickdeschel G, Dalhoff A. The in vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. J Antimicrob Chemother, 1999,43 Suppl. B:25-9. 被引量：1
5Bebear CM, Renaudin H, Boudjadja A ,et al. In vitro activity of BAY 12 - 8039, a new fluoroguinolone, against my, coplasmas, Antimicrob Agents Chemother, 1998,42:703-4. 被引量：1
